Morning movers: Fabrinet falls 10.5% after record revenue
Fabrinet fell 10.54% in delayed pre-market trading even after record quarterly revenue. Infleqtion slid 6.26% after disclosing revenue-recognition corrections and a delayed Q2 filing.
YieldCove Desk
4 min read

The Morning Read carries the broader futures, rates and calendar backdrop. This stock-only brief uses delayed pre-market quotes captured between 05:44 and 05:47 ET on 18 August 2026; thin early trading can move quickly before the opening auction.
A selective morning, not three clean stories
Only two liquid names cleared the full feature bar at the quote cut. FN was -10.54% at $535.51 after record quarterly revenue, while INFQ was -6.26% at $12.57 after disclosing revenue-recognition corrections and a delayed quarterly filing.
| Ticker | Pre-market move | Delayed price | Confirmed catalyst |
|---|---|---|---|
| FN | -10.54% | $535.51 | Record fiscal Q4; market prices a higher expectations bar |
| INFQ | -6.26% | $12.57 | Revenue-recognition corrections and delayed Q2 filing |
FN: -10.54% as record results meet a demanding bar
Fabrinet reported fiscal Q4 revenue of $1.3158 billion, up from $909.7 million a year earlier, and non-GAAP diluted EPS of $4.10, up from $2.65. Fiscal-year revenue reached $4.64 billion, up 36%. Management guided fiscal Q1 revenue to $1.375-$1.425 billion and non-GAAP diluted EPS to $4.10-$4.25. Those are strong figures, but the negative gap shows that backward-looking records were not enough for the expectations already embedded in the stock.
Delayed pre-market
$535.51
-10.54%
Prior close
$598.58
17 Aug 2026
Fiscal Q4 revenue
$1.3158B
vs $909.7M
FN wheel context: a broad chain is not the same as a tight contract
The delayed Cboe file contained 1,132 option series, 18,849 contracts of open interest and 8,754 contracts of prior-session volume. Options do not trade pre-market, and those aggregate totals do not prove that any individual strike has an acceptable bid-ask spread after a double-digit gap.
- Why it matters: optical-communications demand is still expanding, but a high expectations bar can make even record results vulnerable to multiple compression.
- Objective levels: the delayed $535.51 print and Monday’s $598.58 close are the first reference points; neither is a forecast of support or resistance.
- Peers to compare after 09:30 ET: COHR, LITE and AAOI, where regular-session direction can show whether the reaction is company-specific or sector-wide.
- Main risk to the story: a fast pre-market gap can reverse if the earnings call changes the market’s interpretation of guidance, capacity or customer concentration.
INFQ: -6.26% after accounting corrections delay the Q2 filing
Infleqtion said it needed more time for its Q2 Form 10-Q while reviewing revenue recognition and expected-loss accounting on certain projects. The company identified corrections affecting fiscal 2024, fiscal 2025 and Q1 2026, called them immaterial to the prior statements, and said the timing changes should move some revenue from earlier periods into 2026. The filing also linked the issue to a previously disclosed material weakness involving insufficient accounting personnel and review controls.
Delayed pre-market
$12.57
-6.26%
Prior close
$13.41
17 Aug 2026
Periods revised
2024-2026
Timing changes
INFQ wheel context: event risk matters more than aggregate activity
The delayed Cboe file contained 212 option series, 252,741 contracts of open interest and 15,275 contracts of prior-session volume. The next filed financial statements can change how the market reads revenue quality, so pre-open option totals are not a substitute for live post-open spreads and current disclosure.
- Why it matters: even an immaterial correction can raise the discount rate investors apply when a young company already has a material weakness in financial controls.
- Objective levels: the delayed $12.57 print and Monday’s $13.41 close frame the immediate reaction.
- Peers to compare: IONQ and RGTI can help separate an issuer-specific accounting reaction from a broader move in quantum-computing stocks.
- What to watch: the completed Q2 filing, the exact revised periods and whether management’s approximately $43 million 2026 revenue outlook changes.
- Main risk to the story: the company may complete the filing without a thesis-changing revision, while a wider technology rebound could overwhelm the accounting headline.
Also on the radar
- AMLX +21.33% at $26.00 near 05:45 ET: the company still guided its Phase 3 LUCIDITY readout to late August or early September; no trial result was in the official record at the quote cut, so the gap remains anticipation rather than a verified outcome.
- EYPT -0.61% at $4.84 near 05:46 ET: the stock had already fallen 66.98% Monday after the LUGANO Phase 3 primary endpoint was missed in the full dataset; without a new development Tuesday morning, it was not re-led as fresh news.
- INTC -5.10% at $98.21 near 05:47 ET: the highly liquid stock moved with broad technology weakness, but no new issuer catalyst accompanied the Tuesday gap at the cut.
What to watch today
- Before 09:30 ET: watch for a completed INFQ filing or a new issuer release that changes the accounting timeline.
- 09:30 ET — opening auction: compare the first regular-session prices with every delayed print above; pre-market liquidity is thinner.
- After the open — option chains: rebuild live bids, asks and implied volatility before drawing conclusions from prior-session totals.
- During the session: compare FN with optical peers and INFQ with quantum peers to separate company news from sector pressure.
Sources
- [1]Fabrinet fiscal Q4 and FY2026 results — SEC Exhibit 99.1 — Fabrinet / SEC EDGAR · Accessed 2026-08-18 · Tier 1
- [2]Infleqtion Form NT 10-Q — 17 August 2026 — Infleqtion / SEC EDGAR · Accessed 2026-08-18 · Tier 1
- [3]Infleqtion Q2 2026 results — SEC Exhibit 99.1 — Infleqtion / SEC EDGAR · Accessed 2026-08-18 · Tier 1
- [4]EyePoint LUGANO Phase 3 topline results — SEC Exhibit 99.1 — EyePoint / SEC EDGAR · Accessed 2026-08-18 · Tier 1
- [5]Amylyx Q2 2026 results and LUCIDITY timeline — SEC Exhibit 99.1 — Amylyx / SEC EDGAR · Accessed 2026-08-18 · Tier 1
- [6]Fabrinet market quote — CNBC · Accessed 2026-08-18 · Tier 2
- [7]Infleqtion market quote — CNBC · Accessed 2026-08-18 · Tier 2
- [8]U.S. pre-market stock scan — TradingView · Accessed 2026-08-18 · Tier 3
- [9]Fabrinet delayed options quote table — Cboe · Accessed 2026-08-18 · Tier 1
- [10]Infleqtion delayed options quote table — Cboe · Accessed 2026-08-18 · Tier 1
- [11]18 August 2026 Morning Read — YieldCove · Accessed 2026-08-18 · Tier 4
- [12]FMN photonics laboratory photograph and license record — Wikimedia Commons · Accessed 2026-08-18 · Tier 4
This content is for informational and educational purposes only and is not financial advice. Options involve risk and are not suitable for every investor. Do your own research before trading.
Read next

Morning movers: Ross jumps 9.0% after a traffic-led quarter
Ross Stores rose 9.04% in delayed pre-market trading after traffic drove a strong quarter and raised outlook. OSI Systems fell 14.50% on weaker quarterly revenue, while Flowers Foods slipped 3.80% after lowering guidance.

Morning movers: Webull jumps 14.9% after record revenue
Webull rose 14.93% in delayed pre-market trading after record Q2 revenue and trading volume. Wolfspeed fell 12.85% after negative margins, while Moderna gave back 9.68% after Wednesday's historic surge.

Morning movers: Amylyx holds gain after Phase 3 win
Amylyx held a modest pre-market bid after a 63.8% surge on Phase 3 LUCIDITY success. Keysight rose 2.6% on record orders, while Mercury Systems fell 12.4% despite backlog strength.